
    
      The specific aim of this study is to assess the feasibility of using olivamine-containing
      products in the management of patients with compromised nonhealing lower extremity ulcers in
      the Philippines. The primary endpoint of which is to evaluate the efficacy of Olivamine on
      healing of chronic lower extremity ulcers which will be assessed by rate of change in ulcer
      size (wound healing trajectory) and proportion with complete ulcer healing (wound closure) at
      4, 8, 16 and 16 weeks compared to baseline, week 0.
    
  